Daniel Stetson

9PUBLICATIONS

87CO-AUTHORS

Liquid biopsiesCardiology (incl. cardiovascular diseases)Software quality, processes and metricsSocial program evaluationNanotoxicology, health and safety

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 11, 2026

Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0.

|Dec 26, 2025

Lexicon for Clonal Hematopoiesis in Liquid Biopsy.

Robert Tell, Ahmet Zehir, Andrew T Anfora

|Nov 06, 2025

Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.

Cloud P Paweletz, Thomas D Forbes, Laura Yee

|Sep 11, 2024

Reply to S. Sorscher.

James Hadfield, Chris Abbosh, Darren Hodgson

|May 16, 2024

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Dan Stetson, Paul Labrousse, Hugh Russell

|May 01, 2024

Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.

Jacqueline A Shaw, Karen Page, Evie Wren

Pageof 2

Frequent Collaborators

James Hadfield

Dana E Connors

Lauren C Leiman

Dorys Lopez Ramos

Donald J Johann

J Carl Barrett

Jennifer S Lococo

Megan H Cleveland

Christie J Lau

Katheryn Santos

Frequent Collaborators

James Hadfield

Dana E Connors

Lauren C Leiman

Dorys Lopez Ramos